Basal Cell Carcinoma (BCC) Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

DBCOND0040396 (Basal Cell Carcinoma (BCC))Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT02834013Nivolumab and Ipilimumab in Treating Patients With Rare TumorsTreatment